The global market for qPCR and dPCR Instrumentation is estimated at US$7.5 Billion in 2023 and is projected to reach US$13.5 Billion by 2030, growing at a CAGR of 8.7% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the qPCR and dPCR instrumentation market is driven by several factors. The increasing demand for accurate and rapid diagnostic tools in the healthcare sector is a primary driver, particularly in the wake of the COVID-19 pandemic, which underscored the need for reliable nucleic acid testing. The rise in genetic research and personalized medicine is also propelling market growth, as qPCR and dPCR are essential for gene expression analysis, mutation detection, and biomarker discovery. Technological advancements, including the development of more sensitive and high-throughput instruments, are attracting researchers and clinicians seeking to improve their analytical capabilities. Furthermore, the expansion of applications in agriculture, food safety, and environmental monitoring is boosting the adoption of these technologies. Government funding and investments in genomic research and public health initiatives are further supporting market growth. These factors, combined with continuous innovation and the integration of automated and digital solutions, are expected to drive sustained growth in the qPCR and dPCR instrumentation market in the coming years.
The growth in the qPCR and dPCR instrumentation market is driven by several factors. The increasing demand for accurate and rapid diagnostic tools in the healthcare sector is a primary driver, particularly in the wake of the COVID-19 pandemic, which underscored the need for reliable nucleic acid testing. The rise in genetic research and personalized medicine is also propelling market growth, as qPCR and dPCR are essential for gene expression analysis, mutation detection, and biomarker discovery. Technological advancements, including the development of more sensitive and high-throughput instruments, are attracting researchers and clinicians seeking to improve their analytical capabilities. Furthermore, the expansion of applications in agriculture, food safety, and environmental monitoring is boosting the adoption of these technologies. Government funding and investments in genomic research and public health initiatives are further supporting market growth. These factors, combined with continuous innovation and the integration of automated and digital solutions, are expected to drive sustained growth in the qPCR and dPCR instrumentation market in the coming years.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the qPCR and dPCR Reagents & Consumables segment, which is expected to reach US$7.3 Billion by 2030 with a CAGR of a 9.6%. The qPCR and dPCR Instruments segment is also set to grow at 7.4% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $2.3 Billion in 2023, and China, forecasted to grow at an impressive 11.4% CAGR to reach $1.2 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global qPCR and dPCR Instrumentation Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global qPCR and dPCR Instrumentation Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global qPCR and dPCR Instrumentation Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Abbott Laboratories, Inc., Agilent Technologies, Inc., Becton, Dickinson and Company, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 74 Featured):
- Abbott Laboratories, Inc.
- Agilent Technologies, Inc.
- Becton, Dickinson and Company
- Beckman Coulter, Inc.
- Bio-Rad Laboratories, Inc.
- bioMerieux SA
- Asuragen, Inc.
- Analytik Jena AG
- Biocartis NV
- Biotecon Diagnostics GmbH
- BioFire Diagnostics LLC
- Alifax SpA
- Anitoa Systems LLC
- AB ANALITICA s.r.l.
- Bio Molecular Systems
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories, Inc.
- Agilent Technologies, Inc.
- Becton, Dickinson and Company
- Beckman Coulter, Inc.
- Bio-Rad Laboratories, Inc.
- bioMerieux SA
- Asuragen, Inc.
- Analytik Jena AG
- Biocartis NV
- Biotecon Diagnostics GmbH
- BioFire Diagnostics LLC
- Alifax SpA
- Anitoa Systems LLC
- AB ANALITICA s.r.l.
- Bio Molecular Systems
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 573 |
| Published | September 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 7.5 Billion |
| Forecasted Market Value ( USD | $ 13.5 Billion |
| Compound Annual Growth Rate | 8.7% |
| Regions Covered | Global |
